08:47 AM EDT, 05/01/2024 (MT Newswires) -- Repligen ( RGEN ) reported Q1 adjusted earnings Wednesday of $0.28 per diluted share, down from $0.64 a year earlier.
Analysts polled by Capital IQ expected $0.30.
Revenue for the quarter ended March 31 was $151.3 million, down from $182.7 million a year ago.
Analysts surveyed by Capital IQ expected $150.1 million.